Evidence map›Paper›PMID 18335045›Full record

ArticlePloS one2008

A novel non-lens betagamma-crystallin and trefoil factor complex from amphibian skin and its functional implications.

Shu-Bai Liu, Ying-Ying He, Yun Zhang, Wen-Hui Lee, Jin-Qiao Qian, Ren Lai, Yang Jin

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Protein identification from the parotoid macrogland secretion ofThe journal of venomous animals and toxins including tropical diseases · 2019
    Article
  11. Article
  12. Why do we study animal toxins?Dong wu xue yan jiu = Zoological research · 2015
    Review
  13. Article
  14. Review
  15. Host-derived, pore-forming toxin-like protein and trefoil factor complex protects the host against microbial infection.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  16. Article
  17. Ca2+-binding motif of βγ-crystallins.The Journal of biological chemistry · 2014
    Review
  18. Comprehensive transcriptome profiling and functional analysis of the frog (Bombina maxima) immune system.DNA research : an international journal for rapid publication of reports on genes and genomes · 2014
    Article
  19. Article
  20. Characteristics of hemolytic activity induced by skin secretions of the frog Kaloula pulchra hainana.The journal of venomous animals and toxins including tropical diseases · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shu-Bai LiuBiotoxin Units, Key Laboratory of Animal Models and Human Disease Mechanisms, Kunming Institute of Zoology, The Chinese Academy of Sciences, Kunming, Yunnan, China.
Ying-Ying He
Yun Zhang
Wen-Hui Lee
Jin-Qiao Qian
Ren Lai
Yang Jin
Chinese Academy of Sciences · CNKunming Institute of Zoology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn vertebrates, non-lens betagamma-crystallins are widely expressed in various tissues, but their functions are unknown. The molecular mechanisms of trefoil factors, initiators of mucosal healing and being greatly involved in tumorigenesis, have remained elusive. PRINCIPAL

findingsA naturally existing 72-kDa complex of non-lens betagamma-crystallin (alpha-subunit) and trefoil factor (beta-subunit), named betagamma-CAT, was identified from frog Bombina maxima skin secretions. Its alpha-subunit and beta-subunit (containing three trefoil factor domains), with a non-covalently linked form of alphabeta(2), show significant sequence homology to ep37 proteins, a group of non-lens betagamma-crystallins identified in newt Cynops pyrrhogaster and mammalian trefoil factors, respectively. betagamma-CAT showed potent hemolytic activity on mammalian erythrocytes. The specific antiserum against each subunit was able to neutralize its hemolytic activity, indicating that the two subunits are functionally associated. betagamma-CAT formed membrane pores with a functional diameter about 2.0 nm, leading to K(+) efflux and colloid-osmotic hemolysis. High molecular weight SDS-stable oligomers (>240-kDa) were detected by antibodies against the alpha-subunit with Western blotting. Furthermore, betagamma-CAT showed multiple cellular effects on human umbilical vein endothelial cells. Low dosages of betagamma-CAT (25-50 pM) were able to stimulate cell migration and wound healing. At high concentrations, it induced cell detachment (EC(50) 10 nM) and apoptosis. betagamma-CAT was rapidly endocytosed via intracellular vacuole formation. Under confocal microscope, some of the vacuoles were translocated to nucleus and partially fused with nuclear membrane. Bafilomycin A1 (a specific inhibitor of the vacuolar-type ATPase) and nocodazole (an agent of microtuble depolymerizing), while inhibited betagamma-CAT induced vacuole formation, significantly inhibited betagamma-CAT induced cell detachment, suggesting that betagamma-CAT endocytosis is important for its activities. CONCLUSIONS/SIGNIFICANCE: These findings illustrate novel cellular functions of non-lens betagamma-cyrstallins and action mechanism via association with trefoil factors, serving as clues for investigating the possible occurrence of similar molecules and action mechanisms in mammals.

Indexed as

AmphibiansAnimalsChromatography, GelCloning, MolecularCrystallinsElectrophoresis, Polyacrylamide GelPeptidesSkinTrefoil Factor-2CrystallinsPeptidesTrefoil Factor-2

Identifiers

PMID18335045
PMCPMC2262142
OpenAlexW2011841355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.